Recombinant Human Erythropoietin (rHuEPO) Reduces Transfusion Requirements in Anaemia of Prematurity. Northern Int. Med. Coll. J. 2015, 6 (2), 53-56. https://doi.org/10.3329/nimcj.v6i2.23171.